Physiochemical characterization of protein therapeutics, especially of monoclonal antibodies. Comparison of mass spectrometry based techniques such as middle-up and bottom-up methods. Forced degradation experiments to understand degradation pathways and to provide material for method development. Application of these approaches for biosimilar development.